Literature DB >> 9235933

Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1.

S L Wang1, E Z Du, T D Martin, R A Davis.   

Abstract

Stable plasmid-driven expression of the liver-specific gene product cholesterol 7alpha-hydroxylase (7alpha-hydroxylase) was used to alter the cellular content of transcriptionally active sterol response element binding protein 1 (SREBP1). As a result of stable expression of 7alpha-hydroxylase, individual single cell clones expressed varying amounts of mature SREBP1 protein. These single cell clones provided an opportunity to identify SREBP1-regulated genes that may influence the assembly and secretion of apoB-containing lipoproteins. Our results show that in McArdle rat hepatoma cells, which normally do not express 7alpha-hydroxylase, plasmid-driven expression of 7alpha-hydroxylase results in the following: 1) a linear relationship between (i) the cellular content of mature SREBP1 and 7alpha-hydroxylase protein, (ii) the relative expression of 7alpha-hydroxylase mRNA and the mRNA's encoding the enzymes regulating fatty acid, i.e. acetyl-CoA carboxylase and sterol synthesis, i.e. HMG-CoA reductase, (iii) the relative expression of 7alpha-hydroxylase mRNA and microsomal triglyceride transfer protein mRNA, a gene product that is essential for the assembly and secretion of apoB-containing lipoproteins; 2) increased synthesis of all lipoprotein lipids (cholesterol, cholesterol esters, triglycerides, and phospholipids); and 3) increased secretion of apoB100 without any change in apoB mRNA. Cells expressing 7alpha-hydroxylase contained significantly less cholesterol (both free and esterified). The increased cellular content of mature SREBP1 and increased secretion of apoB100 were concomitantly reversed by 25-hydroxycholesterol, suggesting that the content of mature SREBP1, known to be decreased by 25-hydroxycholesterol, mediates the changes in the lipoprotein assembly and secretion pathway that are caused by 7alpha-hydroxylase. These data suggest that several steps in the assembly and secretion of apoB-containing lipoproteins by McArdle hepatoma cells may be coordinately linked through the cellular content of mature SREBP1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9235933     DOI: 10.1074/jbc.272.31.19351

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Authors:  Jian Shen; Donna K Arnett; Laurence D Parnell; Chao-Qiang Lai; Robert J Straka; Paul N Hopkins; Ping An; Mary F Feitosa; José M Ordovás
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

2.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

3.  EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.

Authors:  Deliang Guo; Robert M Prins; Julie Dang; Daisuke Kuga; Akio Iwanami; Horacio Soto; Kelly Y Lin; Tiffany T Huang; David Akhavan; M Benjamin Hock; Shaojun Zhu; Ava A Kofman; Steve J Bensinger; William H Yong; Harry V Vinters; Steve Horvath; Andrew D Watson; John G Kuhn; H Ian Robins; Minesh P Mehta; Patrick Y Wen; Lisa M DeAngelis; Michael D Prados; Ingo K Mellinghoff; Timothy F Cloughesy; Paul S Mischel
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

4.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Authors:  James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

5.  High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.

Authors:  Núria Roglans; Joan C Verd; Cristina Peris; Marta Alegret; Manuel Vázquez; Tomás Adzet; Cristina Díaz; Gonzalo Hernández; Juan C Laguna; Rosa M Sánchez
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

6.  Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism.

Authors:  William T Festuccia; Pierre-Gilles Blanchard; Véronique Turcotte; Mathieu Laplante; Meltem Sariahmetoglu; David N Brindley; Yves Deshaies
Journal:  J Lipid Res       Date:  2009-02-05       Impact factor: 5.922

7.  Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.

Authors:  Takero Nakajima; Naoki Tanaka; Hiroki Kanbe; Atsushi Hara; Yuji Kamijo; Xiaowei Zhang; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Mol Pharmacol       Date:  2009-01-05       Impact factor: 4.436

8.  Inhibition of SREBP1 sensitizes cells to death ligands.

Authors:  Yanina Eberhard; Marcela Gronda; Rose Hurren; Alessandro Datti; Neil MacLean; Troy Ketela; Jason Moffat; Jeffrey L Wrana; Aaron D Schimmer
Journal:  Oncotarget       Date:  2011-03

9.  Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.

Authors:  Caiqin Niu; Zhi Luo; Liuqin Yu; Yang Yang; Yun Chen; Xin Luo; Feiya Lai; Yongyan Song
Journal:  Lipids Health Dis       Date:  2017-09-06       Impact factor: 3.876

10.  High dietary cholesterol and ovariectomy in rats repress gene expression of key markers of VLDL and bile acid metabolism in liver.

Authors:  Zahra Farahnak; Isabelle Côté; Emilienne T Ngo Sock; Jean-Marc Lavoie
Journal:  Lipids Health Dis       Date:  2015-10-09       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.